8-K: Ardent Health Partners Reports Strong Q4 2024 Results and Issues Optimistic 2025 Guidance

Ardent Health Partners announces impressive fourth-quarter and full-year 2024 results, driven by revenue growth and a significant increase in Adjusted EBITDA, while also issuing strong financial guidance for 2025.

Summary

• Ardent Health Partners reported a 19% year-over-year increase in total revenue for the fourth quarter of 2024, reaching $1.61 billion.
• Net income attributable to Ardent Health was $114 million for the quarter, a significant improvement compared to a net loss of $4 million in the same period last year.
• Adjusted EBITDA for the fourth quarter surged by 213% year-over-year to $183 million.
• For the full year 2024, revenue increased by 10% to $5.97 billion, and Adjusted EBITDA grew by 58% to $498 million.
• The company's Adjusted EBITDA margin expanded by 260 basis points to 8.4% for the full year.
• A key factor in the strong performance was the retroactive approval of the New Mexico state directed payment program in November 2024, contributing $94 million to total revenue and $65 million to Adjusted EBITDA in the fourth quarter.
• Excluding the New Mexico payment, full-year revenue was $5.872 billion and Adjusted EBITDA was $433.5 million, still within or above the initial guidance range.
• Ardent Health is issuing full-year 2025 guidance, projecting total revenue between $6.2 billion and $6.45 billion and Adjusted EBITDA between $575 million and $615 million.
• The 2025 guidance includes a projected 19% Adjusted EBITDA growth at the midpoint and a 100 basis point expansion of the Adjusted EBITDA margin.
• The company's balance sheet remains strong, with over $550 million in cash and a lease-adjusted net leverage ratio of 2.9 times as of December 31, 2024.
• Ardent Health acquired 18 urgent care clinics from NextCare Urgent Care on January 3, 2025, expanding its ambulatory operations in New Mexico and Oklahoma.

Sentiment

Score: 8

Explanation: The document presents a highly positive outlook with strong financial results, optimistic guidance, and strategic acquisitions. The management's comments are encouraging, and the company's balance sheet appears healthy. However, the presence of risks and uncertainties, as well as the negative impact of the cybersecurity incident in the past, slightly temper the overall sentiment.

Positives

• Significant revenue growth in Q4 2024, driven by increased adjusted admissions and net patient service revenue per adjusted admission.
• Substantial increase in Adjusted EBITDA, reflecting improved operational efficiency and the impact of the New Mexico state directed payment program.
• Strong full-year 2024 performance, exceeding initial guidance ranges when excluding the New Mexico payment.
• Optimistic 2025 guidance, indicating continued revenue and Adjusted EBITDA growth.
• Healthy balance sheet with a strong cash position and manageable leverage.
• Strategic acquisition of urgent care clinics to expand ambulatory services.

Negatives

• The cybersecurity incident in Q4 2023 negatively impacted year-over-year comparisons.
• The company's results are subject to a number of known and unknown uncertainties and risks, including those set forth below under the heading Forward-Looking Statements.

Risks

• Changes in government healthcare programs, including Medicare and Medicaid, could adversely affect revenues and business.
• Reductions in reimbursement rates paid by commercial payors or an increasing volume of uninsured patients could impact financial performance.
• Security threats, catastrophic events, and other disruptions affecting information technology systems could harm relationships with patients and business partners.
• The highly competitive nature of the healthcare industry and continued industry trends towards clinical transparency and value-based purchasing may impact competitive position.
• Inability to recruit and retain quality physicians, as well as increasing cost to contract with hospital-based physicians.
• Operational, legal and financial risks associated with outsourcing functions to third parties.
• Facilities are heavily concentrated in Texas and Oklahoma, which makes the company sensitive to regulatory, economic and competitive conditions and changes in those states.
• Negative impact of severe weather, climate change, and other factors beyond the company's control, which could restrict patient access to care or cause one or more facilities to close temporarily or permanently.
• Risks related to the Ventas Master Lease and its restrictions and limitations on the business.
• The impact of the company's significant indebtedness.
• The impact of a deterioration of public health conditions associated with a future pandemic, epidemic or outbreak of infectious disease.
• Failure to comply with complex laws and regulations applicable to the healthcare industry or to adjust operations in response to changing laws and regulations.
• The impact of governmental claims or governmental investigations, payor audits and litigation brought against hospitals, physician practices, outpatient facilities or other business operations.
• Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements.
• Inability to or delay in building, acquiring, selling, renovating or expanding healthcare facilities.
• Failure to comply with federal and state laws relating to Medicare and Medicaid enrollment, permit, licensing and accreditation requirements.
• Effects of current and future health reform initiatives, including any that may be undertaken by a new administration, and legal and regulatory restrictions on hospitals that have physician owners.
• Inability to continually enhance hospitals with the most recent technological advances in diagnostic and surgical equipment.
• The company's status as a controlled company.
• Conflicts of interest between the controlling stockholder and other holders of common stock.

Future Outlook

Ardent Health anticipates strong revenue and Adjusted EBITDA growth in 2025, driven by organic and inorganic growth opportunities, enhanced supply chain efficiencies, service line optimization, and ambulatory growth. The company expects volume growth to remain durable and is operating from a position of balance sheet strength.

Management Comments

• We had a strong finish to 2024, highlighted by reported revenue growth of 19% and Adjusted EBITDA growth of well over 200% in the fourth quarter, stated Marty Bonick, President and Chief Executive Officer of Ardent Health.
• For the full-year 2024, we grew revenue 10%, increased Adjusted EBITDA 58%, and expanded Adjusted EBITDA margins 260 basis points.
• We enter 2025 with strong momentum and see encouraging operating environment tailwinds with early indications that volume growth will remain durable this year.

Industry Context

Ardent Health's focus on growing mid-sized urban communities aligns with the broader industry trend of expanding healthcare access in underserved areas. The company's investments in innovative services and technologies reflect the industry's shift towards value-based care and improved patient outcomes. The acquisition of urgent care clinics demonstrates a strategic move to expand ambulatory services, a key area of growth in the healthcare sector.

Comparison to Industry Standards

• HCA Healthcare, a leading hospital operator, reported a revenue increase of 11.3% in Q4 2023, while Ardent Health reported a 19.3% increase in Q4 2024, indicating a stronger growth rate.
• Tenet Healthcare's Adjusted EBITDA margin for 2023 was 8.1%, while Ardent Health's Adjusted EBITDA margin expanded to 8.4% for 2024, suggesting improved profitability.
• LifePoint Health, another major hospital system, has also been focusing on expanding its ambulatory care network, similar to Ardent Health's acquisition of urgent care clinics.

Related Party Transactions

• The company's rent expenses to related parties, specifically Ventas and MPT, are disclosed.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and optimistic guidance.
• Employees may benefit from the company's growth and strategic initiatives.
• Customers should experience improved access to care through the expansion of ambulatory services.
• Suppliers may see increased demand for their products and services.
• Creditors can be reassured by the company's strong financial position and manageable leverage.

Next Steps

• The company will host a conference call on February 27, 2025, to discuss the fourth-quarter financial results.
• Ardent Health will focus on executing its 2025 strategic priorities, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and expanding ambulatory growth.
• The company will continue to assess organic and inorganic growth opportunities.

Key Dates